{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-032624","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2024-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.318527+00:00","generated_at":"2026-06-04T23:40:41.208770+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Astrana Health issues FY2024 revenue $1.65-1.85B, Adj. EBITDA $165-185M","bullets":["FY2023 rev $1.39B, Adj. EBITDA $146.6M, diluted EPS $1.29.","FY2024 guidance: rev $1.65-1.85B, Adj. EBITDA $165-185M, EPS $1.28-1.52.","Closed CFC acquisition Jan 31, 2024; $202M total (cash $152M, equity $20M, milestones $30M).","10,000+ providers, ~900k VBC members; 48% fewer hospital admits vs benchmark.","Care Enablement segment long-term EBITDA margin target 20-30%."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-032624","json":"https://secwatch.observer/filing/0001104659-24-032624.json","markdown":"https://secwatch.observer/filing/0001104659-24-032624.md","text":"https://secwatch.observer/filing/0001104659-24-032624.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924032624/0001104659-24-032624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924032624/tm247913d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:40:41.208770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}